Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma.

Chen, Xiongfeng; Yu, Lili; Hao, Kun; Yin, Xiaoqing; Tu, Mingshu; Cai, Liqing; Zhang, Liangming; Pan, Xiaojie; Gao, Qi; Huang, Yi

Chen, Xiongfeng; Yu, Lili; Hao, Kun; Yin, Xiaoqing; Tu, Mingshu; Cai, Liqing; Zhang, Liangming; Pan, Xiaojie; Gao, Qi; Huang, Yi.

Afiliación

Chen X; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
Yu L; Department of Scientific Research, Fujian Provincial Hospital, Fuzhou, China.
Hao K; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
Yin X; Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China.
Tu M; Research and Development Center, Beijing Glyexo Gene Technology Co., Ltd, Beijing, China.
Cai L; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
Zhang L; Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Pan X; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.
Gao Q; Department of Clinical Laboratory, Fujian Provincial Hospital, Fuzhou, China.
Huang Y; Shengli Clinical Medical College, Fujian Medical University, Fuzhou, China.

Front Oncol ; 12: 935184, 2022.

Article en En | MEDLINE | ID: mdl-36033494

Palabras clave

biomarker; early LUAD diagnosis; fucose-captured strategy; lung adenocarcinoma; serum exosomal miRNA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google